| 7T2 | Name: | (2S)-3-(4-chlorophenyl)-2-(methylamino)propanoic acid | Formula: | C10 H12 Cl N O2 | SMILES: | CN[CH](Cc1ccc(Cl)cc1)C(O)=O | InChi: | InChI=1S/C10H12ClNO2/c1-12-9(10(13)14)6-7-2-4-8(11)5-3-7/h2-5,9,12H,6H2,1H3,(H,13,14)/t9-/m0/s1 | Definition date: | 2021-10-22 | Last modified: | 2023-11-03 | Release date: | 2023-07-26 | Identifier: | (2~{S})-3-(4-chlorophenyl)-2-(methylamino)propanoic acid |
|
| N0X | Name: | (4R)-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-4-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide | Formula: | C16 H18 N4 O2 | SMILES: | O=C(Nc1nncn1C1CC1)C1(C)CCOc2ccccc21 | InChi: | InChI=1S/C16H18N4O2/c1-16(8-9-22-13-5-3-2-4-12(13)16)14(21)18-15-19-17-10-20(15)11-6-7-11/h2-5,10-11H,6-9H2,1H3,(H,18,19,21)/t16-/m1/s1 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4R)-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-4-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide |
|
| N1U | Name: | (3S)-5-bromo-1-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-7-methyl-1,3-dihydro-2H-indol-2-one | Formula: | C18 H18 Br N O4 | SMILES: | COc1ccc(cc1OC)CN1c2c(C)cc(Br)cc2C(O)C1=O | InChi: | InChI=1S/C18H18BrNO4/c1-10-6-12(19)8-13-16(10)20(18(22)17(13)21)9-11-4-5-14(23-2)15(7-11)24-3/h4-8,17,21H,9H2,1-3H3/t17-/m0/s1 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (3S)-5-bromo-1-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-7-methyl-1,3-dihydro-2H-indol-2-one |
|
| N2X | Name: | (3S)-5-bromo-1-[(2-ethoxyphenyl)methyl]-3-hydroxy-1,3-dihydro-2H-indol-2-one | Formula: | C17 H16 Br N O3 | SMILES: | CCOc1ccccc1CN1c2ccc(Br)cc2C(O)C1=O | InChi: | InChI=1S/C17H16BrNO3/c1-2-22-15-6-4-3-5-11(15)10-19-14-8-7-12(18)9-13(14)16(20)17(19)21/h3-9,16,20H,2,10H2,1H3/t16-/m0/s1 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (3S)-5-bromo-1-[(2-ethoxyphenyl)methyl]-3-hydroxy-1,3-dihydro-2H-indol-2-one |
|
| N3I | Name: | 2-(3-chloro-5-methoxyphenyl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C15 H15 Cl N2 O2 | SMILES: | O=C(Nc1cnccc1C)Cc1cc(OC)cc(Cl)c1 | InChi: | InChI=1S/C15H15ClN2O2/c1-10-3-4-17-9-14(10)18-15(19)7-11-5-12(16)8-13(6-11)20-2/h3-6,8-9H,7H2,1-2H3,(H,18,19) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chloro-5-methoxyphenyl)-N-(4-methylpyridin-3-yl)acetamide |
|
| 3WT | Name: | (3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoic acid | Formula: | C10 H21 N O3 | SMILES: | O=C(O)CC(OC)C(NC)C(C)CC | InChi: | InChI=1S/C10H21NO3/c1-5-7(2)10(11-3)8(14-4)6-9(12)13/h7-8,10-11H,5-6H2,1-4H3,(H,12,13)/t7-,8+,10-/m0/s1 | Definition date: | 2014-12-01 | Last modified: | 2023-11-03 | Release date: | 2015-03-25 | Identifier: | (3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoic acid |
|
| N3R | Name: | 5-fluoro-N-[2-(2-methoxyphenoxy)ethyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide | Formula: | C19 H17 F N2 O4 | SMILES: | COc1ccccc1OCCNC(=O)C1=CC(=O)Nc2cccc(F)c21 | InChi: | InChI=1S/C19H17FN2O4/c1-25-15-7-2-3-8-16(15)26-10-9-21-19(24)12-11-17(23)22-14-6-4-5-13(20)18(12)14/h2-8,11H,9-10H2,1H3,(H,21,24)(H,22,23) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 5-fluoro-N-[2-(2-methoxyphenoxy)ethyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide |
|
| N43 | Name: | 5-methoxy-N-[2-(2-methoxyphenoxy)ethyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide | Formula: | C20 H20 N2 O5 | SMILES: | COc1ccccc1OCCNC(=O)C1=CC(=O)Nc2cccc(OC)c12 | InChi: | InChI=1S/C20H20N2O5/c1-25-15-7-3-4-8-16(15)27-11-10-21-20(24)13-12-18(23)22-14-6-5-9-17(26-2)19(13)14/h3-9,12H,10-11H2,1-2H3,(H,21,24)(H,22,23) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 5-methoxy-N-[2-(2-methoxyphenoxy)ethyl]-2-oxo-1,2-dihydroquinoline-4-carboxamide |
|
| N4L | Name: | N-[2-(2-methoxyphenoxy)ethyl]-5-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide | Formula: | C20 H20 N2 O4 | SMILES: | COc1ccccc1OCCNC(=O)C1=CC(=O)Nc2cccc(C)c21 | InChi: | InChI=1S/C20H20N2O4/c1-13-6-5-7-15-19(13)14(12-18(23)22-15)20(24)21-10-11-26-17-9-4-3-8-16(17)25-2/h3-9,12H,10-11H2,1-2H3,(H,21,24)(H,22,23) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-[2-(2-methoxyphenoxy)ethyl]-5-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide |
|
| 3YM | Name: | 3-methoxy-L-tyrosine | Formula: | C10 H13 N O4 | SMILES: | O=C(O)C(N)Cc1cc(OC)c(O)cc1 | InChi: | InChI=1S/C10H13NO4/c1-15-9-5-6(2-3-8(9)12)4-7(11)10(13)14/h2-3,5,7,12H,4,11H2,1H3,(H,13,14)/t7-/m0/s1 | Definition date: | 2012-10-29 | Last modified: | 2023-11-03 | Release date: | 2013-10-30 | Identifier: | 3-methoxy-L-tyrosine |
|
| N5L | Name: | N-(5-amino-4-methylpyridin-3-yl)-2-(3-chlorophenyl)acetamide | Formula: | C14 H14 Cl N3 O | SMILES: | O=C(Nc1cncc(N)c1C)Cc1cccc(Cl)c1 | InChi: | InChI=1S/C14H14ClN3O/c1-9-12(16)7-17-8-13(9)18-14(19)6-10-3-2-4-11(15)5-10/h2-5,7-8H,6,16H2,1H3,(H,18,19) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(5-amino-4-methylpyridin-3-yl)-2-(3-chlorophenyl)acetamide |
|
| N65 | Name: | (2~{S})-2-azanyl-6-[(~{E})-pentan-2-ylideneamino]hexanal | Formula: | C11 H22 N2 O2 | SMILES: | CCCC(C)=NCCCC[CH](N)C(O)=O | InChi: | InChI=1S/C11H22N2O2/c1-3-6-9(2)13-8-5-4-7-10(12)11(14)15/h10H,3-8,12H2,1-2H3,(H,14,15)/b13-9+/t10-/m0/s1 | Definition date: | 2019-11-13 | Last modified: | 2023-11-03 | Release date: | 2020-06-03 | Identifier: | (2~{S})-2-azanyl-6-[(~{E})-pentan-2-ylideneamino]hexanoic acid |
|
| N6F | Name: | (2S)-N-(4-acetamidopyridin-3-yl)-2-(3-chlorophenyl)propanamide | Formula: | C16 H16 Cl N3 O2 | SMILES: | O=C(Nc1cnccc1NC(C)=O)C(C)c1cccc(Cl)c1 | InChi: | InChI=1S/C16H16ClN3O2/c1-10(12-4-3-5-13(17)8-12)16(22)20-15-9-18-7-6-14(15)19-11(2)21/h3-10H,1-2H3,(H,20,22)(H,18,19,21)/t10-/m0/s1 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (2S)-N-(4-acetamidopyridin-3-yl)-2-(3-chlorophenyl)propanamide |
|
| 3ZH | Name: | 11-{4-[(2S)-2-amino-2-carboxyethyl]-3-(8-phenyloctyl)-2,3-dihydro-1H-imidazol-1-yl}undecanoic acid | Formula: | C31 H51 N3 O4 | SMILES: | O=C(O)C(N)CC1=CN(CCCCCCCCCCC(=O)O)CN1CCCCCCCCc2ccccc2 | InChi: | InChI=1S/C31H51N3O4/c32-29(31(37)38)24-28-25-33(22-16-9-5-2-1-3-8-15-21-30(35)36)26-34(28)23-17-10-6-4-7-12-18-27-19-13-11-14-20-27/h11,13-14,19-20,25,29H,1-10,12,15-18,21-24,26,32H2,(H,35,36)(H,37,38)/t29-/m0/s1 | Definition date: | 2014-12-12 | Last modified: | 2023-11-03 | Release date: | 2015-07-29 | Identifier: | 11-{4-[(2S)-2-amino-2-carboxyethyl]-3-(8-phenyloctyl)-2,3-dihydro-1H-imidazol-1-yl}undecanoic acid |
|
| N6X | Name: | N-(5-amino-4-methylpyridin-3-yl)-2-(3-cyanophenyl)acetamide | Formula: | C15 H14 N4 O | SMILES: | O=C(Nc1cncc(N)c1C)Cc1cccc(C#N)c1 | InChi: | InChI=1S/C15H14N4O/c1-10-13(17)8-18-9-14(10)19-15(20)6-11-3-2-4-12(5-11)7-16/h2-5,8-9H,6,17H2,1H3,(H,19,20) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(5-amino-4-methylpyridin-3-yl)-2-(3-cyanophenyl)acetamide |
|
| 40A | Name: | N-[(2S)-2-aminopropyl]-N-[(6-amino-9H-purin-9-yl)acetyl]glycine | Formula: | C12 H17 N7 O3 | SMILES: | O=C(O)CN(C(=O)Cn1c2ncnc(c2nc1)N)CC(N)C | InChi: | InChI=1S/C12H17N7O3/c1-7(13)2-18(4-9(21)22)8(20)3-19-6-17-10-11(14)15-5-16-12(10)19/h5-7H,2-4,13H2,1H3,(H,21,22)(H2,14,15,16)/t7-/m0/s1 | Definition date: | 2010-04-26 | Last modified: | 2023-11-03 | Identifier: | N-[(2S)-2-aminopropyl]-N-[(6-amino-9H-purin-9-yl)acetyl]glycine |
|
| 40C | Name: | N-[(4-amino-2-oxopyrimidin-1(2H)-yl)acetyl]-N-[(2S)-2-aminopropyl]glycine | Formula: | C11 H17 N5 O4 | SMILES: | O=C(N(CC(=O)O)CC(N)C)CN1C=CC(=NC1=O)N | InChi: | InChI=1S/C11H17N5O4/c1-7(12)4-16(6-10(18)19)9(17)5-15-3-2-8(13)14-11(15)20/h2-3,7H,4-6,12H2,1H3,(H,18,19)(H2,13,14,20)/t7-/m0/s1 | Definition date: | 2010-04-26 | Last modified: | 2023-11-03 | Identifier: | N-[(4-amino-2-oxopyrimidin-1(2H)-yl)acetyl]-N-[(2S)-2-aminopropyl]glycine |
|
| 40G | Name: | N-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)acetyl]-N-[(2S)-2-aminopropyl]glycine | Formula: | C12 H17 N7 O4 | SMILES: | O=C(O)CN(C(=O)Cn1c2N=C(NC(=O)c2nc1)N)CC(N)C | InChi: | InChI=1S/C12H17N7O4/c1-6(13)2-18(4-8(21)22)7(20)3-19-5-15-9-10(19)16-12(14)17-11(9)23/h5-6H,2-4,13H2,1H3,(H,21,22)(H3,14,16,17,23)/t6-/m0/s1 | Definition date: | 2010-04-26 | Last modified: | 2023-11-03 | Identifier: | N-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)acetyl]-N-[(2S)-2-aminopropyl]glycine |
|
| N7L | Name: | (1R,2R)-2-(fluoromethyl)-N-(4-methylpyridin-3-yl)cyclopropane-1-carboxamide | Formula: | C11 H13 F N2 O | SMILES: | O=C(Nc1cnccc1C)C1CC1CF | InChi: | InChI=1S/C11H13FN2O/c1-7-2-3-13-6-10(7)14-11(15)9-4-8(9)5-12/h2-3,6,8-9H,4-5H2,1H3,(H,14,15)/t8-,9+/m0/s1 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (1R,2R)-2-(fluoromethyl)-N-(4-methylpyridin-3-yl)cyclopropane-1-carboxamide |
|
| 40T | Name: | N-[(2S)-2-aminopropyl]-N-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine | Formula: | C12 H18 N4 O5 | SMILES: | O=C(N(CC(=O)O)CC(N)C)CN1C=C(C(=O)NC1=O)C | InChi: | InChI=1S/C12H18N4O5/c1-7-3-16(12(21)14-11(7)20)5-9(17)15(4-8(2)13)6-10(18)19/h3,8H,4-6,13H2,1-2H3,(H,18,19)(H,14,20,21)/t8-/m0/s1 | Definition date: | 2010-04-26 | Last modified: | 2023-11-03 | Identifier: | N-[(2S)-2-aminopropyl]-N-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl]glycine |
|
| N8X | Name: | 2-(3,5-dimethylphenyl)-N-(4-methyl-4H-1,2,4-triazol-3-yl)acetamide | Formula: | C13 H16 N4 O | SMILES: | O=C(Nc1nncn1C)Cc1cc(C)cc(C)c1 | InChi: | InChI=1S/C13H16N4O/c1-9-4-10(2)6-11(5-9)7-12(18)15-13-16-14-8-17(13)3/h4-6,8H,7H2,1-3H3,(H,15,16,18) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3,5-dimethylphenyl)-N-(4-methyl-4H-1,2,4-triazol-3-yl)acetamide |
|
| N9I | Name: | 2-(4-methylpyridin-3-yl)-N-(1,2,3,4-tetrahydroisoquinolin-8-yl)acetamide | Formula: | C17 H19 N3 O | SMILES: | Cc1ccncc1CC(=O)Nc1cccc2CCNCc21 | InChi: | InChI=1S/C17H19N3O/c1-12-5-7-18-10-14(12)9-17(21)20-16-4-2-3-13-6-8-19-11-15(13)16/h2-5,7,10,19H,6,8-9,11H2,1H3,(H,20,21) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(4-methylpyridin-3-yl)-N-(1,2,3,4-tetrahydroisoquinolin-8-yl)acetamide |
|
| N9K | Name: | (2~{S})-3-(4-hydroxyphenyl)-2-(methylamino)propanoic acid | Formula: | C10 H13 N O3 | SMILES: | CN[CH](Cc1ccc(O)cc1)C(O)=O | InChi: | InChI=1S/C10H13NO3/c1-11-9(10(13)14)6-7-2-4-8(12)5-3-7/h2-5,9,11-12H,6H2,1H3,(H,13,14)/t9-/m0/s1 | Definition date: | 2019-11-19 | Last modified: | 2023-11-03 | Release date: | 2020-03-04 | Identifier: | (2~{S})-3-(4-hydroxyphenyl)-2-(methylamino)propanoic acid |
|
| NB0 | Name: | 4-[4-(2-fluorophenyl)piperazine-1-carbonyl]quinolin-2(1H)-one | Formula: | C20 H18 F N3 O2 | SMILES: | O=C(C1=CC(=O)Nc2ccccc21)N1CCN(CC1)c1ccccc1F | InChi: | InChI=1S/C20H18FN3O2/c21-16-6-2-4-8-18(16)23-9-11-24(12-10-23)20(26)15-13-19(25)22-17-7-3-1-5-14(15)17/h1-8,13H,9-12H2,(H,22,25) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 4-[4-(2-fluorophenyl)piperazine-1-carbonyl]quinolin-2(1H)-one |
|
| NB6 | Name: | 2-(3-bromophenyl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C14 H13 Br N2 O | SMILES: | O=C(Nc1cnccc1C)Cc1cccc(Br)c1 | InChi: | InChI=1S/C14H13BrN2O/c1-10-5-6-16-9-13(10)17-14(18)8-11-3-2-4-12(15)7-11/h2-7,9H,8H2,1H3,(H,17,18) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-bromophenyl)-N-(4-methylpyridin-3-yl)acetamide |
|